Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients

NCT00579514 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT00579514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00579514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 31, 2000
Completion date
March 31, 2027
Enrollment
21,081 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, breast cancer, colon cancer, kidney cancer, lung cancer, ovarian cancer, prostate cancer